Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

Aurora kinase inhibitor

DRUG CLASS:

Aurora kinase inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

MYC expression + MYC rearrangement	Lymphoma	MYC expression + MYC rearrangement	Lymphoma	Aurora kinase inhibitor Sensitive: C3 – Early Trials Aurora kinase inhibitor Sensitive : C3	Aurora kinase inhibitor Sensitive: C3 – Early Trials Aurora kinase inhibitor Sensitive : C3
AURKB overexpression	Adrenal Cortex Carcinoma	AURKB overexpression	Adrenal Cortex Carcinoma	mitotane + AMG 900 Sensitive: D – Preclinical mitotane + AMG 900 Sensitive : D	mitotane + AMG 900 Sensitive: D – Preclinical mitotane + AMG 900 Sensitive : D
AURKA overexpression	Adrenal Cortex Carcinoma	AURKA overexpression	Adrenal Cortex Carcinoma	mitotane + AMG 900 Sensitive: D – Preclinical mitotane + AMG 900 Sensitive : D	mitotane + AMG 900 Sensitive: D – Preclinical mitotane + AMG 900 Sensitive : D
AURKA overexpression	Adrenal Cortex Carcinoma	AURKA overexpression	Adrenal Cortex Carcinoma	AMG 900 Sensitive: D – Preclinical AMG 900 Sensitive : D	AMG 900 Sensitive: D – Preclinical AMG 900 Sensitive : D
AURKB overexpression	Adrenal Cortex Carcinoma	AURKB overexpression	Adrenal Cortex Carcinoma	AMG 900 Sensitive: D – Preclinical AMG 900 Sensitive : D	AMG 900 Sensitive: D – Preclinical AMG 900 Sensitive : D
TP53 expression	Triple Negative Breast Cancer	TP53 expression	Triple Negative Breast Cancer	ENMD-2076 Sensitive: D – Preclinical ENMD-2076 Sensitive : D	ENMD-2076 Sensitive: D – Preclinical ENMD-2076 Sensitive : D
TP53 mutation	Triple Negative Breast Cancer	TP53 mutation	Triple Negative Breast Cancer	ENMD-2076 Sensitive: D – Preclinical ENMD-2076 Sensitive : D	ENMD-2076 Sensitive: D – Preclinical ENMD-2076 Sensitive : D
BRAF mutation	Thyroid Gland Carcinoma	BRAF mutation	Thyroid Gland Carcinoma	SU6656 Sensitive: D – Preclinical SU6656 Sensitive : D	SU6656 Sensitive: D – Preclinical SU6656 Sensitive : D
RET-PTC1 rearrangement	Thyroid Gland Papillary Carcinoma	RET-PTC1 rearrangement	Thyroid Gland Papillary Carcinoma	CI-1040 + SU6656 Sensitive: D – Preclinical CI-1040 + SU6656 Sensitive : D	CI-1040 + SU6656 Sensitive: D – Preclinical CI-1040 + SU6656 Sensitive : D
RB1 deletion	Estrogen Receptor Positive Breast Cancer	RB1 deletion	Estrogen Receptor Positive Breast Cancer	WEE1 inhibitor + Aurora kinase inhibitor Sensitive: D – Preclinical WEE1 inhibitor + Aurora kinase inhibitor Sensitive : D	WEE1 inhibitor + Aurora kinase inhibitor Sensitive: D – Preclinical WEE1 inhibitor + Aurora kinase inhibitor Sensitive : D